2018 Q4 Form 10-Q Financial Statement

#000094381919000011 Filed on February 01, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2017 Q4
Revenue $651.1M $601.3M
YoY Change 8.29% 13.36%
Cost Of Revenue $276.6M $251.5M
YoY Change 9.98% 13.64%
Gross Profit $374.5M $349.8M
YoY Change 7.07% 13.16%
Gross Profit Margin 57.52% 58.18%
Selling, General & Admin $161.6M $151.8M
YoY Change 6.43% 8.98%
% of Gross Profit 43.14% 43.4%
Research & Development $43.11M $40.64M
YoY Change 6.07% 6.4%
% of Gross Profit 11.51% 11.62%
Depreciation & Amortization $36.10M $29.30M
YoY Change 23.21% 5.78%
% of Gross Profit 9.64% 8.38%
Operating Expenses $217.5M $203.8M
YoY Change 6.71% 7.7%
Operating Profit $157.1M $146.0M
YoY Change 7.58% 21.78%
Interest Expense $7.487M $7.370M
YoY Change 1.59% -407.08%
% of Operating Profit 4.77% 5.05%
Other Income/Expense, Net -$10.81M -$4.251M
YoY Change 154.18% -350.06%
Pretax Income $146.3M $141.8M
YoY Change 3.18% 47.36%
Income Tax $21.63M $132.2M
% Of Pretax Income 14.79% 93.28%
Net Earnings $124.6M $9.527M
YoY Change 1208.27% -87.58%
Net Earnings / Revenue 19.14% 1.58%
Basic Earnings Per Share $0.87 $0.07
Diluted Earnings Per Share $0.86 $0.07
COMMON SHARES
Basic Shares Outstanding 142.9M 142.7M
Diluted Shares Outstanding 144.3M 143.9M

Balance Sheet

Concept 2018 Q4 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $149.5M $858.9M
YoY Change -82.59% 8.98%
Cash & Equivalents $149.5M $858.9M
Short-Term Investments
Other Short-Term Assets $140.4M $116.5M
YoY Change 20.52% 22.63%
Inventory $296.5M $296.1M
Prepaid Expenses
Receivables $477.2M $482.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.064B $1.754B
YoY Change -39.38% 15.39%
LONG-TERM ASSETS
Property, Plant & Equipment $381.5M $401.5M
YoY Change -4.98% 6.81%
Goodwill $1.759B
YoY Change
Intangibles
YoY Change
Long-Term Investments $62.86M $39.80M
YoY Change 57.96%
Other Assets $138.1M $92.80M
YoY Change 48.81% -11.28%
Total Long-Term Assets $2.796B $1.810B
YoY Change 54.52% 0.41%
TOTAL ASSETS
Total Short-Term Assets $1.064B $1.754B
Total Long-Term Assets $2.796B $1.810B
Total Assets $3.860B $3.564B
YoY Change 8.3% 7.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $110.3M $78.40M
YoY Change 40.73% -16.68%
Accrued Expenses $191.6M $187.5M
YoY Change 2.17% -1.26%
Deferred Revenue $72.69M
YoY Change
Short-Term Debt $11.98M $0.00
YoY Change
Long-Term Debt Due $12.00M $1.019B
YoY Change -98.82% 239.93%
Total Short-Term Liabilities $436.4M $1.356B
YoY Change -67.82% 98.77%
LONG-TERM LIABILITIES
Long-Term Debt $1.186B $0.00
YoY Change -100.0%
Other Long-Term Liabilities $202.8M $174.9M
YoY Change 15.95% 268.21%
Total Long-Term Liabilities $1.467B $174.9M
YoY Change 738.95% -80.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $436.4M $1.356B
Total Long-Term Liabilities $1.467B $174.9M
Total Liabilities $1.904B $1.545B
YoY Change 23.26% -4.21%
SHAREHOLDERS EQUITY
Retained Earnings $2.368B
YoY Change
Common Stock $1.461B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.623B
YoY Change
Treasury Stock Shares $41.84M
Shareholders Equity $1.956B $2.020B
YoY Change
Total Liabilities & Shareholders Equity $3.860B $3.564B
YoY Change 8.3% 7.27%

Cashflow Statement

Concept 2018 Q4 2017 Q4
OPERATING ACTIVITIES
Net Income $124.6M $9.527M
YoY Change 1208.27% -87.58%
Depreciation, Depletion And Amortization $36.10M $29.30M
YoY Change 23.21% 5.78%
Cash From Operating Activities $129.5M $132.5M
YoY Change -2.26% 10.51%
INVESTING ACTIVITIES
Capital Expenditures -$20.50M -$18.30M
YoY Change 12.02% 8.28%
Acquisitions
YoY Change
Other Investing Activities -$637.7M -$9.900M
YoY Change 6341.41% 266.67%
Cash From Investing Activities -$658.2M -$28.30M
YoY Change 2225.8% 45.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 450.2M -55.40M
YoY Change -912.64% 15.42%
NET CHANGE
Cash From Operating Activities 129.5M 132.5M
Cash From Investing Activities -658.2M -28.30M
Cash From Financing Activities 450.2M -55.40M
Net Change In Cash -78.50M 48.80M
YoY Change -260.86% -6.87%
FREE CASH FLOW
Cash From Operating Activities $129.5M $132.5M
Capital Expenditures -$20.50M -$18.30M
Free Cash Flow $150.0M $150.8M
YoY Change -0.53% 10.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000943819
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
143300009
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
RESMED INC
dei Entity Small Business
EntitySmallBusiness
false
dei Trading Symbol
TradingSymbol
rmd
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
23099000
CY2017Q4 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
11317000
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
28707000
CY2018Q4 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
15840000
rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
168000
rmd Contingent Consideration Fair Value At Acquisition
ContingentConsiderationFairValueAtAcquisition
rmd Contingent Consideration Fair Value At Acquisition
ContingentConsiderationFairValueAtAcquisition
168000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-25989000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
136490000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
204388000
CY2018Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
111522000
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21634000
CY2018Q4 us-gaap Interest Expense
InterestExpense
7487000
CY2018Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
678000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
226653000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
157078000
CY2017Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4450000
CY2018Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13117000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144349000.00
CY2018Q2 us-gaap Assets Current
AssetsCurrent
1065717000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1063539000
CY2018Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1998206000
CY2018Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2796277000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6123000
rmd Contingent Consideration Payments
ContingentConsiderationPayments
rmd Contingent Consideration Payments
ContingentConsiderationPayments
430000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-272000
CY2018Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1505000
CY2017Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
126390
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
85521
CY2018Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
161036
CY2018Q2 us-gaap Assets
Assets
3063923000
CY2018Q4 us-gaap Assets
Assets
3859816000
CY2018Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6123000
CY2018Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
160427000
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
49881000
CY2018Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
138102000
CY2018Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
125999000
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
185805000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
191564000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
474314000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
488983000
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-224328000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-250317000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1450821000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1460705000
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19258000
rmd Organization And Basis Of Presentation Policy Text Bock
OrganizationAndBasisOfPresentationPolicyTextBock
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:0.05pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Organization and Basis of Presentation</font> </p> <p style="margin:0pt;text-indent:0.05pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 5pt"> <font style="display: inline;font-size:5pt;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:0.05pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">ResMed Inc. (referred to herein as &#x201C;we&#x201D;, &#x201C;us&#x201D;, &#x201C;our&#x201D; or the &#x201C;Company&#x201D;) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group.&nbsp;&nbsp;Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea.&nbsp;&nbsp;Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States.&nbsp;&nbsp;Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Norway and Sweden.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 5pt"> <font style="display: inline;font-size:5pt;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:0.05pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201C;U.S. GAAP&#x201D;) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (&#x201C;SEC&#x201D;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.&nbsp;&nbsp;In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending June&nbsp;30, </font><font style="display: inline;">2019</font><font style="display: inline;">.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 5pt"> <font style="display: inline;font-size:5pt;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:0.05pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The condensed consolidated financial statements for the </font><font style="display: inline;">three and six months ended December&nbsp;31, 2018</font><font style="display: inline;"> and </font><font style="display: inline;">December&nbsp;31, 2017</font><font style="display: inline;"> are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Form 10-K for the year ended </font><font style="display: inline;">June&nbsp;30, 2018</font><font style="display: inline;">.</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2018Q2 rmd Provision For Doubtful Debts
ProvisionForDoubtfulDebts
2277000
CY2018Q4 rmd Provision For Doubtful Debts
ProvisionForDoubtfulDebts
1575000
rmd Receivables Sold Amount
ReceivablesSoldAmount
45842000
rmd Receivables Sold Amount
ReceivablesSoldAmount
60322000
CY2018Q2 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12000000
CY2018Q4 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12000000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
92723000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
110335000
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
483681000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
477191000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25002000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
159603
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
971000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
821935000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
858899000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188701000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149468000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
36964000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-39233000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.70
CY2017Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.74
CY2018Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.37
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
184315866
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
185115251
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
142679632
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
143279017
CY2018Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
571000
CY2018Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
573000
CY2017Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13977000
CY2018Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
60828000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
72685000
CY2018Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
71596000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
76773000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
469535000
CY2017Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
251481000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
512556000
CY2018Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
267369000
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
272000000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1189404000
CY2018Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
281454000
CY2018Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1197478000
CY2018Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
534000
CY2018Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
22000
CY2018Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2012000
CY2018Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3904000
CY2018Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
53818000
CY2018Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32703000
CY2018Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
13084000
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
79057000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
58945000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66453000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.61
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.60
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
15616000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5444000
CY2017Q2 us-gaap Equity Method Investments
EquityMethodInvestments
38324000
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
39795000
CY2018Q2 us-gaap Equity Method Investments
EquityMethodInvestments
41226000
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
62859000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-13853000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-27340000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154599000
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
132238000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54778000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
95489000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-125190000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26145000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32366000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20760000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30570000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2858000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26922000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
272000
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1580000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1580000
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1505000
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
971000
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
215184000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
484926000
CY2018Q2 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
2699000
CY2018Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
560000
CY2018Q2 us-gaap Goodwill
Goodwill
1068944000
CY2018Q4 us-gaap Goodwill
Goodwill
1759045000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-5252000
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
695353000
us-gaap Gross Profit
GrossProfit
655397000
CY2017Q4 us-gaap Gross Profit
GrossProfit
349792000
us-gaap Gross Profit
GrossProfit
726824000
CY2018Q4 us-gaap Gross Profit
GrossProfit
383731000
CY2018Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
29378000
CY2018Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
34480000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
2254000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
2959000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
250250000
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
141765000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
285155000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
146273000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3375000
CY2018Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3375000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
51456000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
192497000
us-gaap Interest Expense
InterestExpense
15155000
CY2017Q4 us-gaap Interest Expense
InterestExpense
7370000
us-gaap Interest Expense
InterestExpense
11195000
us-gaap Interest Paid Net
InterestPaidNet
15155000
us-gaap Interest Paid Net
InterestPaidNet
11195000
CY2018Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
190833000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
220462000
CY2018Q2 us-gaap Inventory Net
InventoryNet
268701000
CY2018Q4 us-gaap Inventory Net
InventoryNet
296511000
CY2018Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
75415000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
73260000
CY2018Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2453000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2789000
us-gaap Investment Income Interest
InvestmentIncomeInterest
9449000
CY2017Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
4579000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1600000
CY2018Q2 us-gaap Liabilities
Liabilities
1004943000
CY2018Q4 us-gaap Liabilities
Liabilities
1903772000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3063923000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3859816000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
511249000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
436443000
CY2018Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
493694000
CY2018Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1467329000
CY2018Q2 us-gaap Long Term Debt
LongTermDebt
269988000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
1185500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-161507000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
595035000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43679000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-806411000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
226534000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
177587000
us-gaap Net Income Loss
NetIncomeLoss
95651000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
9527000
us-gaap Net Income Loss
NetIncomeLoss
230377000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
124639000
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
852000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
343470000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
298554000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8324000
CY2017Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4251000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16056000
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10805000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Operating Expenses
OperatingExpenses
396823000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
203776000
us-gaap Operating Expenses
OperatingExpenses
425613000
us-gaap Operating Income Loss
OperatingIncomeLoss
258574000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
146016000
us-gaap Operating Income Loss
OperatingIncomeLoss
301211000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
273710000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
138098000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
40839000
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
924000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2618000
CY2017Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1460000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3086000
CY2018Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-621000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
3330000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
3127000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8541000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
22844000
us-gaap Payments Of Dividends
PaymentsOfDividends
99553000
us-gaap Payments Of Dividends
PaymentsOfDividends
105567000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
430000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
739249000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
739249000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4624000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4643000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3725000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
27967000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31425000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
124634000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
140369000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20440000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12784000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
50000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1091230000
CY2017Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19558000
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
20863000
CY2018Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19227000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19375000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
7493000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
7253000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
8375000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
7832000
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
860864000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
870488000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
386550000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
381505000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
110000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
352798000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
78058000
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40643000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
81902000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43111000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2432328000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2368339000
us-gaap Revenues
Revenues
1124932000
CY2017Q4 us-gaap Revenues
Revenues
601273000
us-gaap Revenues
Revenues
1239380000
CY2018Q4 us-gaap Revenues
Revenues
651100000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
295666000
CY2017Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
151816000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
308881000
CY2018Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
161579000
us-gaap Share Based Compensation
ShareBasedCompensation
23958000
us-gaap Share Based Compensation
ShareBasedCompensation
25011000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
56.92
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
183
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
289474
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1205826
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1447373
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
60.48
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
69.18
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
46.26
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
52.02
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
101.64
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
101.64
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
895846
CY2018Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11466000
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
11978000
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-423000
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
431000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
2058980000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1956044000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
47744
CY2018Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
12900000
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
41636234
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
200000
CY2018Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1600412000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22800000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1246000
CY2017Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1140000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1622000
CY2018Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1426000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143757000.00
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143855000.00
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144418000.00
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142511000
CY2017Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142715000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142796000
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142923000

Files In Submission

Name View Source Status
0000943819-19-000011-index-headers.html Edgar Link pending
0000943819-19-000011-index.html Edgar Link pending
0000943819-19-000011.txt Edgar Link pending
0000943819-19-000011-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmd-20181231.xml Edgar Link completed
rmd-20181231.xsd Edgar Link pending
rmd-20181231x10q.htm Edgar Link pending
rmd-20181231xex31_1.htm Edgar Link pending
rmd-20181231xex31_2.htm Edgar Link pending
rmd-20181231xex32.htm Edgar Link pending
rmd-20181231_cal.xml Edgar Link unprocessable
rmd-20181231_def.xml Edgar Link unprocessable
rmd-20181231_lab.xml Edgar Link unprocessable
rmd-20181231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending